GlassScriptPhysician profile
Chao-Ming Lin
NPI 1457428351
$1,097.63
in general payments reported to CMS, 2019-2025
19 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $55.54 · 2021: $260 · 2022: $123 · 2023: $137 · 2024: $35.22 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $172.73 | 2019-2022 | |
| Amgen INC. | $157.16 | 2019-2025 | Repatha, Otezla, Otezla |
| Avanir Pharmaceuticals, INC. | $87.53 | 2021-2022 | |
| Lilly USA, LLC | $85.45 | 2020-2024 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $75.80 | 2023 | Nuedexta |
| Pfizer INC. | $66.41 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $62.68 | 2023-2025 | Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $60.88 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $42.85 | 2021-2022 | |
| Abbott Laboratories | $38.72 | 2021-2023 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $37.81 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $37.12 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $33.63 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.63 | 2022 | |
| Glaxosmithkline, LLC. | $25.67 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $22.62 | 2021 | |
| Exact Sciences Corporation | $22.22 | 2025 | Cologuard Collection Kit |
| Eisai INC. | $22.18 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chao-Ming Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.